AWH - Aspira Women's Health Inc.
0.082
-0.012 -14.268%
Share volume: 4,742,494
Last Updated: 04-16-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.09
-0.01
-0.12%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-13-2024 | 11-19-2024 | 03-27-2025 | 05-19-2025 | 08-12-2025 | 11-14-2025 | |
| Cash flow financing | 5.269 M | 1.045 M | 4.093 M | 657.000 K | 4.645 M | -33.000 K | 2.869 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 818.000 K | -2.711 M | 1.171 M | 0.000 | 1.543 M | 0.000 | 2.264 M | |
| Net income | -4.629 M | -3.530 M | -3.547 M | -1.388 M | -1.853 M | -2.666 M | -4.892 M | |
| Depreciation | 29.000 K | 26.000 K | 23.000 K | 14.000 K | 13.000 K | 11.000 K | 50.000 K | |
| Changes in inventories | 9.000 K | 0.000 | 0.000 | 0.000 | -66.000 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -20.000 K | -15.000 K | -2.000 K | 0.000 | 0.000 | 0.000 | -393.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 20.000 K | 15.000 K | 2.000 K | 0.000 | 0.000 | 0.000 | 8.000 K | |
| Cash Change | 818.000 K | -2.711 M | 1.171 M | -364.000 K | 1.543 M | -1.767 M | 2.117 M |